Orion OYJ (OTCMKTS:ORINY) Reaches New 52-Week High – Here’s Why

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s stock price reached a new 52-week high on Wednesday . The company traded as high as $45.25 and last traded at $45.25, with a volume of 598 shares traded. The stock had previously closed at $43.0160.

Orion OYJ Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.64 and a quick ratio of 1.48. The firm’s 50 day moving average is $41.07 and its 200 day moving average is $39.65. The firm has a market cap of $12.77 billion, a P/E ratio of 18.62 and a beta of 0.07.

Orion OYJ (OTCMKTS:ORINY) last announced its earnings results on Friday, July 17th. The company reported $0.58 earnings per share for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%. The business had revenue of $606.38 million during the quarter.

Orion OYJ Company Profile

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.